Global Veterinary Vaccines Market Research Report 2023

Report ID: 1992853 | Published Date: Oct 2024 | No. of Page: 116 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Inactivated Vaccines
        1.2.3 Live Attenuated Vaccines
        1.2.4 Conjugate Vaccines
        1.2.5 Toxoid Vaccines
        1.2.6 Recombinant Vaccines
        1.2.7 DNA Vaccines
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Veterinary Vaccines Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Veterinary Clinic
        1.3.3 Veterinary Hospital
        1.3.4 Veterinary Research Institute
        1.3.5 Retail Pharmacy
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Veterinary Vaccines Market Perspective (2017-2028)
    2.2 Veterinary Vaccines Growth Trends by Region
        2.2.1 Veterinary Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Veterinary Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 Veterinary Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 Veterinary Vaccines Market Dynamics
        2.3.1 Veterinary Vaccines Industry Trends
        2.3.2 Veterinary Vaccines Market Drivers
        2.3.3 Veterinary Vaccines Market Challenges
        2.3.4 Veterinary Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Veterinary Vaccines Players by Revenue
        3.1.1 Global Top Veterinary Vaccines Players by Revenue (2017-2022)
        3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Veterinary Vaccines Revenue
    3.4 Global Veterinary Vaccines Market Concentration Ratio
        3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2021
    3.5 Veterinary Vaccines Key Players Head office and Area Served
    3.6 Key Players Veterinary Vaccines Product Solution and Service
    3.7 Date of Enter into Veterinary Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Vaccines Breakdown Data by Type
    4.1 Global Veterinary Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028)
5 Veterinary Vaccines Breakdown Data by Application
    5.1 Global Veterinary Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Veterinary Vaccines Market Size (2017-2028)
    6.2 North America Veterinary Vaccines Market Size by Country (2017-2022)
    6.3 North America Veterinary Vaccines Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Veterinary Vaccines Market Size (2017-2028)
    7.2 Europe Veterinary Vaccines Market Size by Country (2017-2022)
    7.3 Europe Veterinary Vaccines Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Veterinary Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific Veterinary Vaccines Market Size by Country (2017-2022)
    8.3 Asia-Pacific Veterinary Vaccines Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Veterinary Vaccines Market Size (2017-2028)
    9.2 Latin America Veterinary Vaccines Market Size by Country (2017-2022)
    9.3 Latin America Veterinary Vaccines Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Veterinary Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa Veterinary Vaccines Market Size by Country (2017-2022)
    10.3 Middle East & Africa Veterinary Vaccines Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Elanco
        11.1.1 Elanco Company Detail
        11.1.2 Elanco Business Overview
        11.1.3 Elanco Veterinary Vaccines Introduction
        11.1.4 Elanco Revenue in Veterinary Vaccines Business (2017-2022)
        11.1.5 Elanco Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Veterinary Vaccines Introduction
        11.2.4 Merck Revenue in Veterinary Vaccines Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Merial
        11.3.1 Merial Company Detail
        11.3.2 Merial Business Overview
        11.3.3 Merial Veterinary Vaccines Introduction
        11.3.4 Merial Revenue in Veterinary Vaccines Business (2017-2022)
        11.3.5 Merial Recent Development
    11.4 Zoetis
        11.4.1 Zoetis Company Detail
        11.4.2 Zoetis Business Overview
        11.4.3 Zoetis Veterinary Vaccines Introduction
        11.4.4 Zoetis Revenue in Veterinary Vaccines Business (2017-2022)
        11.4.5 Zoetis Recent Development
    11.5 Advaxis
        11.5.1 Advaxis Company Detail
        11.5.2 Advaxis Business Overview
        11.5.3 Advaxis Veterinary Vaccines Introduction
        11.5.4 Advaxis Revenue in Veterinary Vaccines Business (2017-2022)
        11.5.5 Advaxis Recent Development
    11.6 AmpliPhi Biosciences
        11.6.1 AmpliPhi Biosciences Company Detail
        11.6.2 AmpliPhi Biosciences Business Overview
        11.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
        11.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022)
        11.6.5 AmpliPhi Biosciences Recent Development
    11.7 Aratana Therapeutics
        11.7.1 Aratana Therapeutics Company Detail
        11.7.2 Aratana Therapeutics Business Overview
        11.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
        11.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
        11.7.5 Aratana Therapeutics Recent Development
    11.8 ARKO Labs
        11.8.1 ARKO Labs Company Detail
        11.8.2 ARKO Labs Business Overview
        11.8.3 ARKO Labs Veterinary Vaccines Introduction
        11.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022)
        11.8.5 ARKO Labs Recent Development
    11.9 Bayer
        11.9.1 Bayer Company Detail
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Veterinary Vaccines Introduction
        11.9.4 Bayer Revenue in Veterinary Vaccines Business (2017-2022)
        11.9.5 Bayer Recent Development
    11.10 CanFel Therapeutics
        11.10.1 CanFel Therapeutics Company Detail
        11.10.2 CanFel Therapeutics Business Overview
        11.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
        11.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
        11.10.5 CanFel Therapeutics Recent Development
    11.11 Ceva Animal Health
        11.11.1 Ceva Animal Health Company Detail
        11.11.2 Ceva Animal Health Business Overview
        11.11.3 Ceva Animal Health Veterinary Vaccines Introduction
        11.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022)
        11.11.5 Ceva Animal Health Recent Development
    11.12 Colorado Serum
        11.12.1 Colorado Serum Company Detail
        11.12.2 Colorado Serum Business Overview
        11.12.3 Colorado Serum Veterinary Vaccines Introduction
        11.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022)
        11.12.5 Colorado Serum Recent Development
    11.13 Epitopix
        11.13.1 Epitopix Company Detail
        11.13.2 Epitopix Business Overview
        11.13.3 Epitopix Veterinary Vaccines Introduction
        11.13.4 Epitopix Revenue in Veterinary Vaccines Business (2017-2022)
        11.13.5 Epitopix Recent Development
    11.14 Genus
        11.14.1 Genus Company Detail
        11.14.2 Genus Business Overview
        11.14.3 Genus Veterinary Vaccines Introduction
        11.14.4 Genus Revenue in Veterinary Vaccines Business (2017-2022)
        11.14.5 Genus Recent Development
    11.15 Hygieia Biological Laboratories
        11.15.1 Hygieia Biological Laboratories Company Detail
        11.15.2 Hygieia Biological Laboratories Business Overview
        11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
        11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022)
        11.15.5 Hygieia Biological Laboratories Recent Development
    11.16 ImmuCell
        11.16.1 ImmuCell Company Detail
        11.16.2 ImmuCell Business Overview
        11.16.3 ImmuCell Veterinary Vaccines Introduction
        11.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2017-2022)
        11.16.5 ImmuCell Recent Development
    11.17 Nexvet
        11.17.1 Nexvet Company Detail
        11.17.2 Nexvet Business Overview
        11.17.3 Nexvet Veterinary Vaccines Introduction
        11.17.4 Nexvet Revenue in Veterinary Vaccines Business (2017-2022)
        11.17.5 Nexvet Recent Development
    11.18 Nuovo Biologics
        11.18.1 Nuovo Biologics Company Detail
        11.18.2 Nuovo Biologics Business Overview
        11.18.3 Nuovo Biologics Veterinary Vaccines Introduction
        11.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022)
        11.18.5 Nuovo Biologics Recent Development
    11.19 UBI
        11.19.1 UBI Company Detail
        11.19.2 UBI Business Overview
        11.19.3 UBI Veterinary Vaccines Introduction
        11.19.4 UBI Revenue in Veterinary Vaccines Business (2017-2022)
        11.19.5 UBI Recent Development
    11.20 Valneva
        11.20.1 Valneva Company Detail
        11.20.2 Valneva Business Overview
        11.20.3 Valneva Veterinary Vaccines Introduction
        11.20.4 Valneva Revenue in Veterinary Vaccines Business (2017-2022)
        11.20.5 Valneva Recent Development
    11.21 Vetoquinol
        11.21.1 Vetoquinol Company Detail
        11.21.2 Vetoquinol Business Overview
        11.21.3 Vetoquinol Veterinary Vaccines Introduction
        11.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022)
        11.21.5 Vetoquinol Recent Development
    11.22 Virbac
        11.22.1 Virbac Company Detail
        11.22.2 Virbac Business Overview
        11.22.3 Virbac Veterinary Vaccines Introduction
        11.22.4 Virbac Revenue in Veterinary Vaccines Business (2017-2022)
        11.22.5 Virbac Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Inactivated Vaccines
    Table 3. Key Players of Live Attenuated Vaccines
    Table 4. Key Players of Conjugate Vaccines
    Table 5. Key Players of Toxoid Vaccines
    Table 6. Key Players of Recombinant Vaccines
    Table 7. Key Players of DNA Vaccines
    Table 8. Key Players of Others
    Table 9. Global Veterinary Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Veterinary Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Veterinary Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Veterinary Vaccines Market Share by Region (2017-2022)
    Table 13. Global Veterinary Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Veterinary Vaccines Market Share by Region (2023-2028)
    Table 15. Veterinary Vaccines Market Trends
    Table 16. Veterinary Vaccines Market Drivers
    Table 17. Veterinary Vaccines Market Challenges
    Table 18. Veterinary Vaccines Market Restraints
    Table 19. Global Veterinary Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Veterinary Vaccines Market Share by Players (2017-2022)
    Table 21. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
    Table 22. Ranking of Global Top Veterinary Vaccines Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Veterinary Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Veterinary Vaccines Product Solution and Service
    Table 26. Date of Enter into Veterinary Vaccines Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Veterinary Vaccines Revenue Market Share by Type (2017-2022)
    Table 30. Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Veterinary Vaccines Revenue Market Share by Type (2023-2028)
    Table 32. Global Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Veterinary Vaccines Revenue Market Share by Application (2017-2022)
    Table 34. Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Veterinary Vaccines Revenue Market Share by Application (2023-2028)
    Table 36. North America Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific Veterinary Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific Veterinary Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Elanco Company Detail
    Table 47. Elanco Business Overview
    Table 48. Elanco Veterinary Vaccines Product
    Table 49. Elanco Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 50. Elanco Recent Development
    Table 51. Merck Company Detail
    Table 52. Merck Business Overview
    Table 53. Merck Veterinary Vaccines Product
    Table 54. Merck Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 55. Merck Recent Development
    Table 56. Merial Company Detail
    Table 57. Merial Business Overview
    Table 58. Merial Veterinary Vaccines Product
    Table 59. Merial Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 60. Merial Recent Development
    Table 61. Zoetis Company Detail
    Table 62. Zoetis Business Overview
    Table 63. Zoetis Veterinary Vaccines Product
    Table 64. Zoetis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 65. Zoetis Recent Development
    Table 66. Advaxis Company Detail
    Table 67. Advaxis Business Overview
    Table 68. Advaxis Veterinary Vaccines Product
    Table 69. Advaxis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 70. Advaxis Recent Development
    Table 71. AmpliPhi Biosciences Company Detail
    Table 72. AmpliPhi Biosciences Business Overview
    Table 73. AmpliPhi Biosciences Veterinary Vaccines Product
    Table 74. AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 75. AmpliPhi Biosciences Recent Development
    Table 76. Aratana Therapeutics Company Detail
    Table 77. Aratana Therapeutics Business Overview
    Table 78. Aratana Therapeutics Veterinary Vaccines Product
    Table 79. Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 80. Aratana Therapeutics Recent Development
    Table 81. ARKO Labs Company Detail
    Table 82. ARKO Labs Business Overview
    Table 83. ARKO Labs Veterinary Vaccines Product
    Table 84. ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 85. ARKO Labs Recent Development
    Table 86. Bayer Company Detail
    Table 87. Bayer Business Overview
    Table 88. Bayer Veterinary Vaccines Product
    Table 89. Bayer Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 90. Bayer Recent Development
    Table 91. CanFel Therapeutics Company Detail
    Table 92. CanFel Therapeutics Business Overview
    Table 93. CanFel Therapeutics Veterinary Vaccines Product
    Table 94. CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 95. CanFel Therapeutics Recent Development
    Table 96. Ceva Animal Health Company Detail
    Table 97. Ceva Animal Health Business Overview
    Table 98. Ceva Animal Health Veterinary VaccinesProduct
    Table 99. Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 100. Ceva Animal Health Recent Development
    Table 101. Colorado Serum Company Detail
    Table 102. Colorado Serum Business Overview
    Table 103. Colorado Serum Veterinary VaccinesProduct
    Table 104. Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 105. Colorado Serum Recent Development
    Table 106. Epitopix Company Detail
    Table 107. Epitopix Business Overview
    Table 108. Epitopix Veterinary VaccinesProduct
    Table 109. Epitopix Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 110. Epitopix Recent Development
    Table 111. Genus Company Detail
    Table 112. Genus Business Overview
    Table 113. Genus Veterinary VaccinesProduct
    Table 114. Genus Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 115. Genus Recent Development
    Table 116. Hygieia Biological Laboratories Company Detail
    Table 117. Hygieia Biological Laboratories Business Overview
    Table 118. Hygieia Biological Laboratories Veterinary VaccinesProduct
    Table 119. Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 120. Hygieia Biological Laboratories Recent Development
    Table 121. ImmuCell Company Detail
    Table 122. ImmuCell Business Overview
    Table 123. ImmuCell Veterinary VaccinesProduct
    Table 124. ImmuCell Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 125. ImmuCell Recent Development
    Table 126. Nexvet Company Detail
    Table 127. Nexvet Business Overview
    Table 128. Nexvet Veterinary VaccinesProduct
    Table 129. Nexvet Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 130. Nexvet Recent Development
    Table 131. Nuovo Biologics Company Detail
    Table 132. Nuovo Biologics Business Overview
    Table 133. Nuovo Biologics Veterinary VaccinesProduct
    Table 134. Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 135. Nuovo Biologics Recent Development
    Table 136. UBI Company Detail
    Table 137. UBI Business Overview
    Table 138. UBI Veterinary VaccinesProduct
    Table 139. UBI Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 140. UBI Recent Development
    Table 141. Valneva Company Detail
    Table 142. Valneva Business Overview
    Table 143. Valneva Veterinary VaccinesProduct
    Table 144. Valneva Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 145. Valneva Recent Development
    Table 146. Vetoquinol Company Detail
    Table 147. Vetoquinol Business Overview
    Table 148. Vetoquinol Veterinary VaccinesProduct
    Table 149. Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 150. Vetoquinol Recent Development
    Table 151. Virbac Company Detail
    Table 152. Virbac Business Overview
    Table 153. Virbac Veterinary VaccinesProduct
    Table 154. Virbac Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 155. Virbac Recent Development
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Veterinary Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. Inactivated Vaccines Features
    Figure 3. Live Attenuated Vaccines Features
    Figure 4. Conjugate Vaccines Features
    Figure 5. Toxoid Vaccines Features
    Figure 6. Recombinant Vaccines Features
    Figure 7. DNA Vaccines Features
    Figure 8. Others Features
    Figure 9. Global Veterinary Vaccines Market Share by Application in 2021 & 2028
    Figure 10. Veterinary Clinic Case Studies
    Figure 11. Veterinary Hospital Case Studies
    Figure 12. Veterinary Research Institute Case Studies
    Figure 13. Retail Pharmacy Case Studies
    Figure 14. Others Case Studies
    Figure 15. Veterinary Vaccines Report Years Considered
    Figure 16. Global Veterinary Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Veterinary Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Veterinary Vaccines Market Share by Region: 2021 VS 2028
    Figure 19. Global Veterinary Vaccines Market Share by Players in 2021
    Figure 20. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2021
    Figure 22. North America Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. North America Veterinary Vaccines Market Share by Country (2017-2028)
    Figure 24. United States Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Veterinary Vaccines Market Share by Country (2017-2028)
    Figure 28. Germany Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Veterinary Vaccines Market Share by Region (2017-2028)
    Figure 36. China Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Veterinary Vaccines Market Share by Country (2017-2028)
    Figure 44. Mexico Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Veterinary Vaccines Market Share by Country (2017-2028)
    Figure 48. Turkey Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Saudi Arabia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 51. Merck Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 52. Merial Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 53. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 54. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 55. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 56. Aratana Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 57. ARKO Labs Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 58. Bayer Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 59. CanFel Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 60. Ceva Animal Health Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 61. Colorado Serum Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 62. Epitopix Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 63. Genus Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 64. Hygieia Biological Laboratories Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 65. ImmuCell Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 66. Nexvet Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 67. Nuovo Biologics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 68. UBI Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 69. Valneva Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 70. Vetoquinol Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 71. Virbac Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac
Frequently Asked Questions
Veterinary Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Veterinary Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Veterinary Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Vibrating Feeder

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More